Abstract
Our experience with intracavernous injection of prostaglandin E1 in spinal cord injured patients with neurogenic erectile dysfunction included 15 men. They received testing dosage starting from 5 µg with increasing dosage (maximum 20 µg) to achieve a rigid erection of Schramek's grade 5 and lasting for at least 20 min. All of them had achieved functional erection adequate for coitus after treatment except one patient who had been proved to have venogenic impotence. We found that intracavernous injection of prostaglandin E1 had significantly improved the erectile condition. No systemic side effect or any other complication was noted except that pain at the injection site was complained of in two patients with incomplete lesion.
Similar content being viewed by others
Article PDF
References
Virag R . Intracavernous injection of papaverine for erectile failure. Lancet 1982; 2: 938.
Brindley G S . Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatry 1983; 143: 332.
Girdley F M et al. Intracavernous self-injection for impotence: a long term therapeutic option? Experience in 78 patients. J Urol 1988; 140: 972–974.
Lakin M M et al. Intracavernous injection therapy: analysis of results and complications. J Urol 1990; 143: 1138–1141.
Levine S B et al. Side effects of self-administration of intracavernous papaverine and phentolamine for treatment of impotence. J Urol 1989; 141: 54–57.
Ishii N et al. Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence. Jpn J Urol 1986; 77: 954.
Bodner D R et al. The application of intracavernous injection of vasoactive medications for erection in men with SCI. J Urol 1987; 138: 310–311.
Sidi A A et al. Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with SCI. J Urol 1987; 138: 539–542.
Lloyd L K et al. Intracavernous pharmacotherapy for management of erectile dysfunction in SCI. Paraplegia 1989; 27: 457–464.
Schramek P et al. Prostaglandin El in erectile dysfunction. Efficiency and incidence of priapism. Br J Urol 1990; 65: 68–71.
Somers M F . Sexuality and sexual functioning. In: Somers MF (ed). Spinal Cord Injury Functional Rehabilitation, 1st edn. Appleton & Lange: Connecticut 1992; p 281.
Linsenmeyer T A . Infertility in men with spinal cord injury. Arch Phys Med Rehabil 1991; 72: 747–753.
Allen R P et al. Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin El. J Urol 1992; 148: 1181–1183.
Ishii N et al. Intracavernous injection of prostaglandin El for the treatment of erectile impotence. J Urol 1989; 141: 323–325.
Waldhauser M et al. Efficiency and side effects of prostaglandin El in the treatment of erectile dysfunction. J Urol 1988; 140: 525–527.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tang, S., Chu, N. & Wong, M. Intracavernous injection of prostaglandin e1 in spinal cord injured patients with erectile dysfunction. A preliminary report. Spinal Cord 33, 731–733 (1995). https://doi.org/10.1038/sc.1995.153
Issue Date:
DOI: https://doi.org/10.1038/sc.1995.153
Keywords
This article is cited by
-
Semen Quality in Males with Spinal Cord Injury: Medical and Psychological Aspect
Sexuality and Disability (2008)